U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841848) titled 'Fundus Camera Module for Early Detection of Alzheimer's Disease' on Feb. 17.
Brief Summary: Alzheimer's Disease (AD) affects tens of millions of people just in Europe. It is typically detected in its late stage when irreversible damage has already occurred, and current treatments are mostly conservative or palliative. Here we developed a device performing high-resolution multispectral imaging of the eye fundus to detect AD in its early stage. After clinical testing, the proposed device has a high potential to become a method for routine population screening, as it is non-invasive and affordable. The possibility of AD detection in an...